Cobas reagents
Ended Awarded Last action
- Contract number
- 36C25023N0057
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $134,537
Award facts
- Contract value 100% obligated
- $134,536.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$107,122 | |
| Funding Only Action | $18,322 | |
| Original award | $223,337 |
About this award
Roche Diagnostics Corporation was awarded a delivery order valued at $134,536.79 for COBAS reagents by the Department of Veterans Affairs' Veterans Integrated Service Network 10 on October 1, 2022, with an ultimate completion date of September 30, 2023. This firm fixed-price contract represents a child order under a larger indefinite delivery vehicle and involves no set-aside designation. The work will be performed at the contractor's facility in Castleton, Indiana. COBAS reagents are critical consumables used in Roche's laboratory diagnostic systems, which support molecular testing, clinical chemistry analysis, and other diagnostic capabilities across the VA's healthcare network.
As a leading manufacturer of in vitro diagnostic solutions, Roche Diagnostics Corporation supplies comprehensive laboratory testing equipment and reagents to federal healthcare agencies, particularly the Department of Veterans Affairs and Defense Health Agency. This delivery order exemplifies the company's ongoing relationship with the VA, supporting the agency's diagnostic testing infrastructure and patient care operations. The contract falls under the company's established GSA Schedule vehicles, including the In Vitro Diagnostics, Reagents, Test schedule, which enables efficient acquisition of Roche's medical diagnostic technologies through pre-negotiated pricing and terms across multiple VA service networks.
Quick answers
Who was awarded contract 36C25023N0057?
36C25023N0057 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 10 (Veterans Health Administration) on October 1, 2022.
How much is contract 36C25023N0057 worth?
The government has obligated $134,537 on 36C25023N0057.
Is contract 36C25023N0057 an order under another contract?
Yes. 36C25023N0057 is a delivery order under 36C25019D0017, an indefinite delivery contract.
Was contract 36C25023N0057 competed?
The extent of competition for 36C25023N0057 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award